Skip to content

Orange Juice Consumption and Glucose Metabolism and Antioxidative Status

Impact of Orange Juice Consumption on Glucose Homeostasis and Antioxidative Status in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02974478
Enrollment
26
Registered
2016-11-28
Start date
2016-04-30
Completion date
2016-12-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

orange juice consumption, glucose homeostasis, antioxidative status

Brief summary

Aim of the study is to investigate the impact of orange juice consumption (with meals or between meals) as well as sugar sweetened beverage (SSB) consumption (between meals) on glucose homeostasis and antioxidative status.

Detailed description

Duration of the study is 3x three weeks including one wash-out week each followed by two weeks of juice/SSB consumption under free living conditions. During wash-out weeks consumption of orange juice or citrus fruits is restricted. During intervention weeks, participants are asked to eat three regular meals per day without snacking. Intervention weeks are (i) orange juice consumption with meals (ii) orange juice consumption between meals and (iii) SSB consumption between meals. Daily energy intake with orange juice/SSB is 20% of individual energy requirement. Additional caloric beverages (SSB, juice, coffee with sugar/milk, alcohol) are not allowed. At the beginning and the end of each intervention phase insulin sensitivity and antioxidative status are assessed.

Interventions

DIETARY_SUPPLEMENTOrange juice with meals

orange juice (20% of energy requirement/day)

DIETARY_SUPPLEMENTOrange juice between meals

orange juice (20% of energy requirement/day)

DIETARY_SUPPLEMENTSugar sweetened beverage between meals

Sugar sweetened beverage (20% of energy requirement/day)

Sponsors

University of Hohenheim
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy

Exclusion criteria

* regular use of medication, * smoking, * chronic disease, * vegan/vegetarian diet, * fructose intolerance, * irregular eating behaviour (less then 3 meals/day)

Design outcomes

Primary

MeasureTime frameDescription
changes in daylong glycaemia between pre and post intervention periodstwo weeksmeasured via continuous glucose monitoring \[mg/dL\]

Secondary

MeasureTime frameDescription
changes in uric acid between pre and post intervention periodstwo weeksmeasured via uric acid serum levels \[mg/dL\]
changes in insulin sensitivity between pre and post intervention periodstwo weeksmeasured via Matsuda-Index from oral glucose tolerance test data
changes in antioxidative status between pre and post intervention periodstwo weeksmeasured via vitamin c blood levels \[mg/L\]

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026